This study reveals the mechanism by which the C5a-C5aR1 pathway regulates tumor-associated macrophage (TAM) anti-tumor immune responses and highlights the potential of targeting C5aR1 for clinical applications [48]. The gene discussed is C5AR1; the disease is neoplasm.